CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells
Eun Ji Kim, Ki Ho Kang, Ji Hyeon Ju
Korean J Intern Med. 2017;32(1):42-61.   Published online 2017 Jan 1     DOI: https://doi.org/10.3904/kjim.2016.198
Citations to this article as recorded by Crossref logo
Stem cell transplantation for Huntington’s diseases
Kyung-Ah Choi, Yeonho Choi, Sunghoi Hong
Methods.2018; 133: 104.     CrossRef
CRISPR genome editing and its medical applications
Mohammad-Reza Mahmoudian-sani, Gholamreza Farnoosh, Ali Mahdavinezhad, Massoud Saidijam
Biotechnology & Biotechnological Equipment.2018; 32(2): 286.     CrossRef
Different Chondrogenic Potential among Human Induced Pluripotent Stem Cells from Diverse Origin Primary Cells
Yeri Alice Rim, Yoojun Nam, Narae Park, Hyerin Jung, Yeonsue Jang, Jennifer Lee, Ji Hyeon Ju
Stem Cells International.2018; 2018: 1.     CrossRef
Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells
Beatrice Ho, Nicole Pek, Boon-Seng Soh
International Journal of Molecular Sciences.2018; 19(4): 936.     CrossRef
Induced pluripotent stem cell models of lysosomal storage disorders
Daniel K. Borger, Benjamin McMahon, Tamanna Roshan Lal, Jenny Serra-Vinardell, Elma Aflaki, Ellen Sidransky
Disease Models & Mechanisms.2017; 10(6): 691.     CrossRef
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
Seung Min Kim, Yoosoo Yang, Seung Ja Oh, Yeonsun Hong, Minkoo Seo, Mihue Jang
Journal of Controlled Release.2017; 266: 8.     CrossRef